HemaXis Micro Blood Sampling
  • HOME
  • PRODUCTS
    • HEMAXIS DB
      Whole Blood Collection
    • HEMAXIS DX
      Plasma/Serum Collection
    • DOCUMENTATION
      Instructions, App Notes, Articles
  • APPLICATIONS
    • OVERVIEW
    • PEth TESTING
    • IMMUNOSUPPRESSANT MONITORING
    • DRUG OF ABUSE
    • IN-COMPETITION DRUG TESTING
    • COVID-19 SEROLOGY TESTING
    • WORKPLACE COVID-19 Serology testing
  • COMPANY
    • ABOUT US
    • NEWSROOM
  • TRY HEMAXIS
  • Menu

EXPANDING THE POTENTIAL
OF BLOOD SAMPLING

HemaXis simplifies and reduces the cost of blood sampling, enabling to collect blood anywhere and at anytime.

ORDER HemaXis DB10

UNLEASHING LABS
TO STAY WELL

HemaXis brings together the power of labs to test and monitor health with the desire to stay well. To achieve this, physicians require information about their patient’s physiology and how food, drugs and the environment affect their health.

The HemaXis micro blood sampling platform uses microfluidics to collect and prepare accurate volume controlled samples of whole blood, plasma and serum. This platform promises to increase the analysis potential of the dried blood format and to revolutionize blood sampling. 

HemaXis DB 10 for whole blood collection is now available for sale in Europe and the United States.

SEE HEMAXIS DB 10 IN ACTION
hemaxis laboratory

DEMOCRATIZING BLOOD SAMPLING

The Hemaxis platform aims to simplify and reduce the cost of blood sampling by replacing the blood tube, nurse, collection center, cold storage, and centrifuge with reliable and easy to use devices based on microfluidic technology.

IMPROVED USER EXPERIENCE 
no intimidating needles, blood sampling anywhere and at anytime

RELIABILITY OF SAMPLES
high sample quality, standardized (controlled volume) and secured blood collection

SIMPLIFIED LOGISTICS
no collection center, cold storage nor centrifugation required

FITS WITHIN EXISTING LABORATORY WORKFLOWS 
high throughput due to automation capacity of standard filter card

LOWER COSTS
less time, energy and resources required

COMPARE HEMAXIS TO TRADITIONAL BLOOD SAMPLING

QUALITATIVE AND QUANTITATIVE APPLICATIONS

Blood Circulating Bio-Markers
Clinical Chemistry
DNA / RNA
Pre-Clinical and Clinical Trials, DMPK
Epidemiology and population studies
Therapeutic Drug Monitoring
Drugs of Abuse Screening
Trace Element Screening
Pediatric and neonatal screening
Bio banking
Disease surveillance

INTERESTED IN MICRO BLOOD SAMPLING?

SEE OUR SERVICES

HEMAXIS DX
THE WORLDS 1st MICROFLUIDIC DEVICE TO PROVIDE PASSIVE PLASMA SEPARATION

Revolutionizing the potential of micro blood samples at the fingertip

DISCOVER MORE

COMMERCIAL PARTNERS

Realizing big ideas requires big collaboration. We are working together with established clinical labs and pharmaceutical companies to fully leverage the potential of micro blood sampling.

ACQ logo
Unilabs logo
UCI logo
Cansford logo
Genica logo

WHAT THE EXPERTS ARE SAYING

“Unilabs Switzerland has partnered with DBS System to use their product HemaXis DB10 because it is innovative in allowing true quantitation capability on a dried blood spot.  It’s a present and  future opportunity to greatly improve patient care and comfort and to broaden our diagnostic offer. The device is precise, convenient, easy to use and is up to the high quality standards we have in place in our labs.”

Dr. Dany MercanScientific Head (West Switzerland) at Unilabs Switzerland

“Our need for an efficient in-competition blood sampling solution led to a partnership with DBS System. HemaXis DB10 enables the collection of reliable capillary blood samples in a minimally invasive way that is compatible with precise laboratory analyses.”

Prof. Martial SaugyHead of Research and Expertise in anti-Doping Sciences (REDs) in University of Lausanne

“We have been using HemaXis™ DB10 for immunosuppressant monitoring for several years now. It proved to be a reliable tool that significantly improves patient comfort: routine therapeutic monitoring of grafted patients can be done from a few drops of blood. Patients wouldn’t go back to conventional venipuncture.”

Dr. Dirk Jan MoesPharmacometrician at Leiden University Medical Center

“The project of DBS System is innovative and brings a concrete application of the microfluidic technology to the medical field. DBS System platform opens up multiple doors to further integrate high potential innovations for blood sampling and sample preparation, especially with respect to biomedical analysis requirements.”

Prof. Philippe RenaudHead of Microsystems Laboratory 4 of the Swiss Institute of Technology of Lausanne (EPFL)

“We have been using HemaXis over the last year in a variety of tests and always to our full satisfaction. It allows us new possibilities that were unthinkable previously. The time and therefore cost saving it brings to the lab operation is undeniable and most importantly, it does not require extra investments, because it doesn’t disturb the existing and certified workflow.”

Dr. Marc AugsburgerHead of the Unit of Forensic Toxicology CURML – CHUV / HUG

“Dried blood spots technology provides an attractive alternative to conventional venipuncture, the product developed by DBS System allows us to provide an accurate measure of the drug concentration, the possibility to concomitantly obtain dried plasma spot from this technology will unambiguously push child therapeutic drug monitoring forward.”

Prof. Marc Ansari, MD, PDHead of Onco-Hematology Unit Department of Paediatrics Geneva University Hospitals (HUG) and Founder and Director of CANSEARCH Foundation

“DBS System brings an innovative solution solving challenges related to blood collection, their products offer a concrete solution to simplify and standardize the micro-blood collection.”

Prof. Denis HochstrasserHead of Department of Genetic and Laboratory Medicine of the Geneva University Hospitals (HUG)

“Genetic Medico-Diagnostic Laboratory Genica and Genome Centre Bulgaria are among the leading genetic centres in Bulgaria.  Most of our samples are not taken in our lab, but they are transported to us from different country territory as well as from abroad. Compared to the traditional blood collection process, Hemaxis micro sampling offers an efficient, faster, significantly cheaper, and safe sampling. It is highly suitable for transportation, storage and processing.”

Prof. Albena TodorovaHead of Laboratory Genica and Genome Centre Bulgaria
PreviousNext

MOST RECENT NEWS

COVID-19 Serology Workplace Testing

https://hemaxis.com/wp-content/uploads/2020/05/COVID-19-Serology-Workplace1-2.jpg 1290 1920 hemaxisdbs http://hemaxis.com/wp-content/uploads/2016/08/hemaxis-logo-x1.png hemaxisdbs2020-05-27 15:05:502020-06-23 16:43:19COVID-19 Serology Workplace Testing
coronavirus

HemaXis is contributing in clinical trial to better understand COVID-19

https://hemaxis.com/wp-content/uploads/2020/05/CoronaVirusHeader-Final-2-3.jpg 793 1920 hemaxisdbs http://hemaxis.com/wp-content/uploads/2016/08/hemaxis-logo-x1.png hemaxisdbs2020-05-04 17:34:292020-05-04 17:36:11HemaXis is contributing in clinical trial to better understand COVID-19
Patient meeting a doctor

Are blood tests possible without seeing a doctor?

https://hemaxis.com/wp-content/uploads/2020/03/image-from-rawpixel-id-260884-jpeg.jpg 1281 1920 hemaxisdbs http://hemaxis.com/wp-content/uploads/2016/08/hemaxis-logo-x1.png hemaxisdbs2020-03-03 16:01:362020-03-04 15:16:02Are blood tests possible without seeing a doctor?
MORE NEWS FROM HEMAXIS

DISCLAIMER

HemaXis DB is a FDA Class 1 medical device. HemaXis DX is in development and for research purposes only. Use of HemaXis devices in Laboratory Developed Tests (LDTs) requires further processing including the establishment of performance characteristics and successful validation by the laboratory in a manner consistent with local regulatory requirements.

By using this website you are agreeing to our Terms and Conditions.

CONTACT

DBS System SA
Rte des Avouillons 6
CH-1196 Gland
Switzerland

Tel: +41 (0) 78 624 70 15
Email: info@dbs-system.ch

LEGAL DOCUMENTS

Read Our Privacy Policy
Read Our General Terms and Conditions of Sale
Read Our Shipping Information

CONNECT WITH US

Linkedin

Twitter

YouTube

Newsletter

© Copyright - Hemaxis 2018 All rights reserved | The Webb Agency
Scroll to top